Back
Vanguard S&P Small-Cap 600 Index Fund ETF Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
70
VIOO
Vanguard S&P Small-Cap 600 Index Fund ETF
Last Price:
$105.26
Seasonality Move:
-0.41%
Sell
47
SRPT
Sarepta Therapeutics
Last Price:
$19.39
Seasonality Move:
37.39%
Buy
70
Vanguard S&P Small-Cap 600 Index Fund ETF (VIOO)
is a Buy
Is Vanguard S&P Small-Cap 600 Index Fund ETF a Buy, Sell or Hold?
-
The current Vanguard S&P Small-Cap 600 Index Fund ETF [VIOO] share price is $104.72. The Score for VIOO is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
VIOO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $19.23. The Score for SRPT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VIOO Stock Price Chart
What is Vanguard S&P Small-Cap 600 Index Fund ETF's stock price today?
-
The Vanguard S&P Small-Cap 600 Index Fund ETF share price today is $104.72Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VIOO is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $19.23Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight buying pressure.
VIOO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 25.86 | Buy |
Relative Strength Index (14 RSI): | 62.9 | Buy |
Chaikin Money Flow: | 46461 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (99.05 - 103.79) | Buy |
Bollinger Bands (100): | (92.54 - 102.66) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.67 | Buy |
Relative Strength Index (14 RSI): | 33.14 | Sell |
Chaikin Money Flow: | 1476404 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.86 - 32.3) | Sell |
Bollinger Bands (100): | (26.38 - 83.98) | Sell |
VIOO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 104.45 | Buy |
20-day SMA: | 101.71 | Buy |
50-day SMA: | 99.32 | Buy |
200-day SMA: | 103.62 | Buy |
8-day EMA: | 74.94 | Buy |
20-day EMA: | 41.23 | Buy |
50-day EMA: | 18.98 | Buy |
200-day EMA: | 5.11 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.58 | Buy |
20-day SMA: | 19.63 | Sell |
50-day SMA: | 32.35 | Sell |
200-day SMA: | 88.22 | Sell |
8-day EMA: | 13.55 | Buy |
20-day EMA: | 7.46 | Buy |
50-day EMA: | 3.44 | Buy |
200-day EMA: | 0.93 | Buy |
Vanguard S&P Small-Cap 600 Index Fund ETF Earnings Growth & VIOO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.75 per share, a decrease this year of $5.87 per share, and an increase next year of $5.35 per share.
Vanguard S&P Small-Cap 600 Index Fund ETF Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |